Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	3.91e-07	3	147	3	GO:0008389
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA3 GLRA1 GLRA2	7.69e-06	6	147	3	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA3 GLRA1 GLRA2	7.69e-06	6	147	3	GO:0016934
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1 GLRA2	2.13e-05	8	147	3	GO:0005237
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	ABL1 ABL2 WEE1 BAZ1B PTK2	2.17e-05	46	147	5	GO:0004715
GeneOntologyMolecularFunction	glycine-gated chloride ion channel activity	GLRA3 GLRA2	5.38e-05	2	147	2	GO:0022852
GeneOntologyMolecularFunction	glycine binding	GLRA3 GLRA1 GLRA2	1.34e-04	14	147	3	GO:0016594
GeneOntologyMolecularFunction	protein kinase activity	ABL1 ABL2 ATR WEE1 PDK2 BAZ1B PTK2 GRK1 TTBK2 MTOR GUCY2D PNCK MAPK6 MAST3	1.43e-04	600	147	14	GO:0004672
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ABL1 ABL2 POLR1A ATR WEE1 PDK2 POLR2G BAZ1B HKDC1 PTK2 GRK1 TTBK2 TAMM41 MTOR GUCY2D PNCK MAPK6 MAST3	1.88e-04	938	147	18	GO:0016772
GeneOntologyMolecularFunction	amino acid binding	GLRA3 SHMT2 GRIN2D GLRA1 GLRA2	2.03e-04	73	147	5	GO:0016597
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ABL1 ABL2 ATR WEE1 PDK2 BAZ1B HKDC1 PTK2 GRK1 TTBK2 MTOR GUCY2D PNCK MAPK6 MAST3	2.39e-04	709	147	15	GO:0016773
GeneOntologyMolecularFunction	kinase activity	ABL1 ABL2 ATR WEE1 PDK2 BAZ1B HKDC1 PTK2 GRK1 TTBK2 MTOR GUCY2D PNCK MAPK6 MAST3	5.24e-04	764	147	15	GO:0016301
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR BAZ1B	5.31e-04	5	147	2	GO:0141003
GeneOntologyMolecularFunction	neuropilin binding	ABL1 SEMA3A	5.31e-04	5	147	2	GO:0038191
GeneOntologyMolecularFunction	semaphorin receptor binding	SEMA3A SEMA6D SEMA3B	6.21e-04	23	147	3	GO:0030215
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2A6 CYP2A7 CYP2A13	7.06e-04	24	147	3	GO:0008392
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP2A6 CYP2A7 CYP2A13	1.00e-03	27	147	3	GO:0008391
GeneOntologyMolecularFunction	chemorepellent activity	SEMA3A SEMA6D SEMA3B	1.24e-03	29	147	3	GO:0045499
GeneOntologyMolecularFunction	transmitter-gated channel activity	GLRA3 GRIN2D GLRA1 GLRA2	1.35e-03	65	147	4	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GLRA3 GRIN2D GLRA1 GLRA2	1.35e-03	65	147	4	GO:0022824
GeneOntologyBiologicalProcess	cellular response to ethanol	GLRA3 ITPR2 GLRA1 GLRA2	2.64e-05	25	145	4	GO:0071361
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	3.94e-05	10	145	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	3.94e-05	10	145	3	GO:0009804
GeneOntologyCellularComponent	dendrite	SHANK1 FLNA ABL1 ABL2 DTNB GLRA3 SHH MPDZ ACTN2 TXNRD2 GRM4 PTK2 SEMA3A SLC9A5 MTOR GLRA1 ELAVL4	9.69e-05	858	145	17	GO:0030425
GeneOntologyCellularComponent	dendritic tree	SHANK1 FLNA ABL1 ABL2 DTNB GLRA3 SHH MPDZ ACTN2 TXNRD2 GRM4 PTK2 SEMA3A SLC9A5 MTOR GLRA1 ELAVL4	9.97e-05	860	145	17	GO:0097447
GeneOntologyCellularComponent	glycinergic synapse	GLRA3 GLRA1 GLRA2	3.42e-04	20	145	3	GO:0098690
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	1.79e-06	4	144	3	IPR008067
Domain	Glycine_rcpt_A	GLRA3 GLRA1 GLRA2	1.79e-06	4	144	3	IPR008127
Domain	F_actin_bind	ABL1 ABL2	5.90e-05	2	144	2	PF08919
Domain	F-actin_binding	ABL1 ABL2	5.90e-05	2	144	2	IPR015015
Domain	FABD	ABL1 ABL2	5.90e-05	2	144	2	SM00808
Domain	PC_rep	PSMD1 ANAPC1	1.76e-04	3	144	2	PF01851
Domain	Proteasome/cyclosome_rpt	PSMD1 ANAPC1	1.76e-04	3	144	2	IPR002015
Domain	Semaphorin	SEMA3A SEMA6D SEMA3B	4.65e-04	20	144	3	IPR027231
Domain	FATC	ATR MTOR	5.81e-04	5	144	2	PF02260
Domain	GABAA/Glycine_rcpt	GLRA3 GLRA1 GLRA2	7.10e-04	23	144	3	IPR006028
Domain	FAT	ATR MTOR	8.68e-04	6	144	2	PS51189
Domain	FATC	ATR MTOR	8.68e-04	6	144	2	PS51190
Domain	FAT	ATR MTOR	8.68e-04	6	144	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR MTOR	8.68e-04	6	144	2	IPR003151
Domain	FATC_dom	ATR MTOR	8.68e-04	6	144	2	IPR003152
Domain	P-type_ATPase_IIC	ATP1A4 ATP4A	8.68e-04	6	144	2	IPR005775
Domain	PIK_FAT	ATR MTOR	8.68e-04	6	144	2	IPR014009
Domain	FATC	ATR MTOR	8.68e-04	6	144	2	SM01343
Domain	Kinase-like_dom	ABL1 ABL2 ATR WEE1 PTK2 GRK1 TTBK2 MTOR GUCY2D PNCK MAPK6 MAST3	1.02e-03	542	144	12	IPR011009
Domain	S1	POLR2G SRBD1	1.60e-03	8	144	2	PF00575
Domain	Semap_dom	SEMA3A SEMA6D SEMA3B	1.72e-03	31	144	3	IPR001627
Domain	SEMA	SEMA3A SEMA6D SEMA3B	1.72e-03	31	144	3	PS51004
Domain	Sema	SEMA3A SEMA6D SEMA3B	1.72e-03	31	144	3	SM00630
Domain	Sema	SEMA3A SEMA6D SEMA3B	1.72e-03	31	144	3	PF01403
Domain	VIT	VWA5B2 ITIH2	2.55e-03	10	144	2	PS51468
Domain	VIT	VWA5B2 ITIH2	2.55e-03	10	144	2	IPR013694
Domain	ANF_lig-bd_rcpt	GRIN2D GRM4 GUCY2D	2.88e-03	37	144	3	IPR001828
Domain	ANF_receptor	GRIN2D GRM4 GUCY2D	2.88e-03	37	144	3	PF01094
Domain	Peripla_BP_I	GRIN2D GRM4 GUCY2D	3.35e-03	39	144	3	IPR028082
Domain	S1	POLR2G SRBD1	3.70e-03	12	144	2	SM00316
Domain	S1_dom	POLR2G SRBD1	3.70e-03	12	144	2	IPR022967
Domain	S1_domain	POLR2G SRBD1	3.70e-03	12	144	2	IPR003029
Domain	C8	VWF ZAN	3.70e-03	12	144	2	PF08742
Domain	TIL	VWF ZAN	3.70e-03	12	144	2	PF01826
Domain	Unchr_dom_Cys-rich	VWF ZAN	4.36e-03	13	144	2	IPR014853
Domain	C8	VWF ZAN	4.36e-03	13	144	2	SM00832
Domain	Prot_kinase_dom	ABL1 ABL2 WEE1 PTK2 GRK1 TTBK2 GUCY2D PNCK MAPK6 MAST3	4.67e-03	489	144	10	IPR000719
Domain	PSI	SEMA3A SEMA6D SEMA3B	4.72e-03	44	144	3	IPR016201
Domain	PROTEIN_KINASE_DOM	ABL1 ABL2 WEE1 PTK2 GRK1 TTBK2 GUCY2D PNCK MAPK6 MAST3	4.94e-03	493	144	10	PS50011
Domain	Neurotransmitter_ion_chnl_CS	GLRA3 GLRA1 GLRA2	5.03e-03	45	144	3	IPR018000
Domain	Cyt_P450_E_grp-I	CYP2A6 CYP2A7 CYP2A13	5.03e-03	45	144	3	IPR002401
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH9	5.06e-03	14	144	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH9	5.06e-03	14	144	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH9	5.06e-03	14	144	2	IPR013602
Domain	DHC_N2	DNAH3 DNAH9	5.06e-03	14	144	2	PF08393
Domain	TIL_dom	VWF ZAN	5.06e-03	14	144	2	IPR002919
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH9	5.06e-03	14	144	2	IPR011704
Domain	MT	DNAH3 DNAH9	5.06e-03	14	144	2	PF12777
Domain	AAA_8	DNAH3 DNAH9	5.06e-03	14	144	2	PF12780
Domain	AAA_5	DNAH3 DNAH9	5.06e-03	14	144	2	PF07728
Domain	Neur_chan_memb	GLRA3 GLRA1 GLRA2	5.35e-03	46	144	3	PF02932
Domain	PSI	SEMA3A SEMA6D SEMA3B	5.35e-03	46	144	3	SM00423
Domain	Neurotrans-gated_channel_TM	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	IPR006029
Domain	-	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	2.70.170.10
Domain	Neur_chan_LBD	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	PS00236
Domain	Neur_channel	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	IPR006201
Domain	Neur_chan_lig-bd	GLRA3 GLRA1 GLRA2	5.68e-03	47	144	3	IPR006202
Domain	DHC_fam	DNAH3 DNAH9	5.80e-03	15	144	2	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH9	5.80e-03	15	144	2	PF03028
Domain	PI3/4_kinase_CS	ATR MTOR	5.80e-03	15	144	2	IPR018936
Domain	Dynein_heavy_dom	DNAH3 DNAH9	5.80e-03	15	144	2	IPR004273
Domain	VWF_type-D	VWF ZAN	6.60e-03	16	144	2	IPR001846
Domain	-	ATR MTOR	6.60e-03	16	144	2	1.10.1070.11
Domain	VWFD	VWF ZAN	6.60e-03	16	144	2	PS51233
Domain	ATPase_P-typ_TM_dom	ATP1A4 ATP4A	6.60e-03	16	144	2	IPR023298
Domain	PI3Kc	ATR MTOR	6.60e-03	16	144	2	SM00146
Domain	VWD	VWF ZAN	6.60e-03	16	144	2	SM00216
Domain	-	ATP1A4 ATP4A	6.60e-03	16	144	2	1.20.1110.10
Domain	VWD	VWF ZAN	6.60e-03	16	144	2	PF00094
Domain	VWF_A	VWA5B2 VWF ITIH2 ANAPC1	7.25e-03	99	144	4	IPR002035
Domain	ATPase_P-typ_cation-transptr_C	ATP1A4 ATP4A	7.44e-03	17	144	2	IPR006068
Domain	Cation_ATPase_C	ATP1A4 ATP4A	7.44e-03	17	144	2	PF00689
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 FLNA EPPK1 ABL1 KMT5C UBR4 GRIN2D TXNRD2 MBD3 MADD ITPR2 GET4 CELSR2 CANT1 MTOR KLHL21 KBTBD11 CPSF1 RIPOR1 ZFYVE26 ABTB2	9.27e-09	1105	147	21	35748872
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	31645370
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	8188299
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	2703500
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	22217847
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	22890016
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA3 GLRA1 GLRA2	7.40e-08	3	147	3	17920294
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	3346244
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	2733794
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	8484736
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	1417950
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	24045421
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	32987105
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	7.40e-08	3	147	3	2415518
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	VMP1 HYOU1 ATR SLC39A1 LANCL1 PGAP4 WDR25 MADD ITPR2 SEMA3A FZD6 CELSR2 CANT1 GLCE ENTPD6 SEMA3B CPSF1 TMEM131 TAP2 SLC37A4	1.83e-07	1201	147	20	35696571
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA3 GLRA1 GLRA2	2.95e-07	4	147	3	9051263
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	2.95e-07	4	147	3	10490589
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13	2.95e-07	4	147	3	1970547
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	2.95e-07	4	147	3	9408084
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA3 GLRA1 GLRA2	2.95e-07	4	147	3	19528249
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA3 GLRA1 GLRA2	2.95e-07	4	147	3	21486797
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	2.95e-07	4	147	3	7565685
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA3 GLRA1 GLRA2	7.35e-07	5	147	3	21850450
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA3 GLRA1 GLRA2	7.35e-07	5	147	3	18721822
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13	1.47e-06	6	147	3	7668294
Pubmed	ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.	ABL1 ABL2 CPSF1	1.47e-06	6	147	3	37040401
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13	1.47e-06	6	147	3	8587134
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	2.56e-06	7	147	3	9630227
Pubmed	Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.	GLRA3 GLRA1 GLRA2	2.56e-06	7	147	3	22988142
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13	2.56e-06	7	147	3	14630516
Pubmed	Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton.	FLNA ACTN2 PTK2	2.56e-06	7	147	3	8609175
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	EPPK1 HYOU1 UBR4 PSMB4 MYO18A LANCL1 PSMD1 ACTN2 ARPC1B ITIH2 TTBK2 MTOR TAP2	4.05e-06	647	147	13	26618866
Pubmed	Resveratrol improves health and survival of mice on a high-calorie diet.	CYP2A6 CYP2A7 CYP2A13 CIDEA	4.26e-06	26	147	4	17086191
Pubmed	Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder.	CYP2A6 CYP2A7 CYP2A13	6.10e-06	9	147	3	37838304
Pubmed	Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival.	ABL1 VWF ABL2	6.10e-06	9	147	3	23840065
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNA CYP2A6 CYP2A13 HYOU1 GLS2 PCDHGC5 DTNB UBR4 EML6 MYO18A HKDC1 PSMD1 ACTN2 SRBD1 OR5AR1 MAPK6 ATP1A4 SPAG17 STAG2	1.15e-05	1442	147	19	35575683
Pubmed	Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors.	GLRA1 GLRA2	1.77e-05	2	147	2	16144831
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA3 GLRA1	1.77e-05	2	147	2	16420443
Pubmed	Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases.	ABL1 ABL2	1.77e-05	2	147	2	15987940
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	1.77e-05	2	147	2	12325023
Pubmed	Presence of ethanol-sensitive and ethanol-insensitive glycine receptors in the ventral tegmental area and prefrontal cortex in mice.	GLRA1 GLRA2	1.77e-05	2	147	2	34378188
Pubmed	Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.	CYP2A6 CYP2A13	1.77e-05	2	147	2	30876690
Pubmed	Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.	ABL1 TUSC2	1.77e-05	2	147	2	17486070
Pubmed	CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.	CYP2A6 CYP2A13	1.77e-05	2	147	2	21395539
Pubmed	Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.	CYP2A6 CYP2A13	1.77e-05	2	147	2	12162851
Pubmed	Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.	CYP2A6 CYP2A13	1.77e-05	2	147	2	1302041
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA3 GLRA1	1.77e-05	2	147	2	23834509
Pubmed	Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.	CYP2A6 CYP2A13	1.77e-05	2	147	2	8395817
Pubmed	The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection.	ABL1 ABL2	1.77e-05	2	147	2	22665498
Pubmed	Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.	CYP2A6 CYP2A13	1.77e-05	2	147	2	25804444
Pubmed	Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis.	ATR WEE1	1.77e-05	2	147	2	30645202
Pubmed	Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.	CYP2A6 CYP2A13	1.77e-05	2	147	2	1520280
Pubmed	Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels.	GLRA3 GLRA2	1.77e-05	2	147	2	27382060
Pubmed	CircVMP1 promotes glycolysis and disease progression by upregulating HKDC1 in colorectal cancer.	VMP1 HKDC1	1.77e-05	2	147	2	38009649
Pubmed	Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.	CYP2A6 CYP2A13	1.77e-05	2	147	2	23917075
Pubmed	Structure of the human alpha 2 subunit gene of the glycine receptor--use of vectorette and Alu-exon PCR.	GLRA1 GLRA2	1.77e-05	2	147	2	8973915
Pubmed	CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.	CYP2A6 CYP2A7	1.77e-05	2	147	2	16636685
Pubmed	The expression of the non-receptor tyrosine kinases Arg and c-abl is differently modulated in B lymphoid cells at different stages of differentiation.	ABL1 ABL2	1.77e-05	2	147	2	12220663
Pubmed	Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.	CYP2A6 CYP2A13	1.77e-05	2	147	2	27902773
Pubmed	PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.	MTOR EPAS1	1.77e-05	2	147	2	26432405
Pubmed	Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.	ABL1 GRIN2D	1.77e-05	2	147	2	10777567
Pubmed	Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes.	ABL1 ABL2	1.77e-05	2	147	2	11279004
Pubmed	Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.	PTK2 MTOR	1.77e-05	2	147	2	26892465
Pubmed	Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ.	CYP2A6 CYP2A13	1.77e-05	2	147	2	30154104
Pubmed	Selective glycine receptor α2 subunit control of crossover inhibition between the on and off retinal pathways.	GLRA3 GLRA2	1.77e-05	2	147	2	22399754
Pubmed	Expression of CYP2A genes in human liver and extrahepatic tissues.	CYP2A7 CYP2A13	1.77e-05	2	147	2	10353262
Pubmed	Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin.	ABL1 ABL2	1.77e-05	2	147	2	17686996
Pubmed	Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.	CYP2A6 CYP2A13	1.77e-05	2	147	2	21418183
Pubmed	ABL tyrosine kinases: evolution of function, regulation, and specificity.	ABL1 ABL2	1.77e-05	2	147	2	20841568
Pubmed	Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.	ATR WEE1	1.77e-05	2	147	2	29605721
Pubmed	mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling.	SEMA3A MTOR	1.77e-05	2	147	2	27246732
Pubmed	LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells.	MTOR KDM1A	1.77e-05	2	147	2	29749504
Pubmed	Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.	CYP2A6 CYP2A13	1.77e-05	2	147	2	19923441
Pubmed	Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.	CYP2A6 CYP2A13	1.77e-05	2	147	2	12499123
Pubmed	Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.	CYP2A6 CYP2A13	1.77e-05	2	147	2	22497566
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA3 GLRA1	1.77e-05	2	147	2	19959465
Pubmed	Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.	ABL1 ABL2	1.77e-05	2	147	2	20181697
Pubmed	The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.	CYP2A6 CYP2A13	1.77e-05	2	147	2	26363552
Pubmed	Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.	CYP2A6 CYP2A13	1.77e-05	2	147	2	2712571
Pubmed	KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.	MTOR KDM1A	1.77e-05	2	147	2	34673129
Pubmed	c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.	ABL1 ABL2	1.77e-05	2	147	2	20150913
Pubmed	Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.	CYP2A6 CYP2A13	1.77e-05	2	147	2	22696418
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA3 GLRA1	1.77e-05	2	147	2	21486794
Pubmed	Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.	ABL1 ABL2	1.77e-05	2	147	2	28555614
Pubmed	Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.	CYP2A6 CYP2A13	1.77e-05	2	147	2	30222954
Pubmed	Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.	CYP2A6 CYP2A13	1.77e-05	2	147	2	7543189
Pubmed	Loss of dendrite stabilization by the Abl-related gene (Arg) kinase regulates behavioral flexibility and sensitivity to cocaine.	ABL1 ABL2	1.77e-05	2	147	2	19805386
Pubmed	Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.	GLRA1 GLRA2	1.77e-05	2	147	2	2155780
Pubmed	Characterization and regulation of sex-specific mouse steroid hydroxylase genes.	CYP2A6 CYP2A13	1.77e-05	2	147	2	2372744
Pubmed	c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.	ABL1 ABL2	1.77e-05	2	147	2	21892207
Pubmed	Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.	PTK2 MTOR	1.77e-05	2	147	2	26295809
Pubmed	The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.	CYP2A6 CYP2A7	1.77e-05	2	147	2	2322567
Pubmed	Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.	CYP2A6 CYP2A13	1.77e-05	2	147	2	21473878
Pubmed	The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.	CYP2A6 CYP2A13	1.77e-05	2	147	2	7581481
Pubmed	Expression and alternative splicing of the cytochrome P-450 CYP2A7.	CYP2A6 CYP2A7	1.77e-05	2	147	2	7864805
Pubmed	Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.	CYP2A6 CYP2A13	1.77e-05	2	147	2	28298240
Pubmed	Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice.	CYP2A6 CYP2A13	1.77e-05	2	147	2	6309775
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	3.35e-07	3	141	3	int:CYP2A7
Cytoband	Xp22.1	SAT1 SMS	2.12e-04	7	147	2	Xp22.1
Cytoband	1q44	OR2L8 OR2L3 OR2L5 SMYD3	4.48e-04	110	147	4	1q44
Cytoband	19q13.1	NFKBIB CATSPERG ATP4A	7.47e-04	55	147	3	19q13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2L8 OR2L3 OR2L5 SMYD3	7.91e-04	128	147	4	chr1q44
GeneFamily	Glycine receptors	GLRA3 GLRA1 GLRA2	1.83e-06	5	104	3	868
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA3A SEMA6D SEMA3B	1.96e-04	20	104	3	736
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13	1.06e-03	35	104	3	1001
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SHANK1 CNTN4 WEE1 HKDC1 GRIN2D CIDEA TMEM145 ADAMTS16	3.25e-08	149	145	8	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Striatum / BrainAtlas - Mouse McCarroll V32	SHANK1 SHH GRIN2D CIDEA TMEM132C MOXD1 TMEM145	2.77e-07	133	145	7	d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	WEE1 ASAH2 GINS1 MAPK6 CATSPERG EPAS1 SPRYD4	5.21e-07	146	145	7	2d907e50206c4762a8baa741363bc7f0a04bd84e
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	VWA5B2 GLS2 SHH GRIN2D TTBK2 TMEM145 ELAVL4	1.63e-06	173	145	7	7e3897868dd3f6e4974f593c60649a543ffc8693
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	VWA5B2 GLS2 SHH GRIN2D TTBK2 TMEM145 ELAVL4	2.28e-06	182	145	7	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTN4 SLC16A9 HKDC1 EFHD1 UMOD ABTB2 SLC25A48	2.28e-06	182	145	7	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN SYCP2 ADAMTS16 ELAVL4 ATP1A4 SPAG17 DNAH9	2.45e-06	184	145	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN SYCP2 ADAMTS16 ELAVL4 ATP1A4 SPAG17 DNAH9	2.45e-06	184	145	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN SYCP2 ADAMTS16 ELAVL4 ATP1A4 SPAG17 DNAH9	2.45e-06	184	145	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	(4)_Endothelial_cells-(4)_Lymph_vessel\|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CNTN4 PGAP4 SEMA3A DHODH KBTBD11 ELAVL4 CEP19	3.47e-06	194	145	7	9735b86d3b2480a0b34d8aab8e7bd609d83c2454
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	VWF MPDZ ACTN2 FZD6 TMEM132C SEMA3B EPAS1	4.25e-06	200	145	7	7136936d05ab344a560cf159684c881063b5430d
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 CYP2A13 GLS2 GRM4 TMEM145	8.12e-06	145	145	6	1e52e3c615b49e7388cd58a04e74cafac9552447
ToppCell	Striatum-Neuronal-Inhibitory\|Striatum / BrainAtlas - Mouse McCarroll V32	SHANK1 SHH GRIN2D MOXD1 GLRA1 TMEM145	1.28e-05	157	145	6	c41ff3fe9de7187575114febfe9bd8733366fb8a
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF GRIN2D FZD6 RBP7 SAT1 EPAS1	2.21e-05	173	145	6	b0ff9808e38cb64a734ced498cd0546728746cd5
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GALNT15 VWF ARPC1B FZD6 RBP7 EPAS1	3.43e-05	187	145	6	d6765854154557794815514c0aa355bc74b8523e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GLRA3 SEMA3A TMEM132C GLCE ADAMTS16	3.44e-05	113	145	5	feb3c6a7723263d58e5ce020a0097fedfcf78ca8
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF ARPC1B RBP7 MOXD1 SAT1 EPAS1	3.64e-05	189	145	6	feedac2751ed770f80bc56fec31662b5b3826f58
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAGLB ABL1 ARPC1B MBD3 G6PC3 SPRYD4	3.64e-05	189	145	6	c2a936f1008d691dac900f033a8a0f425dcf310b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic-conventional_dendritic_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAGLB ABL1 ARPC1B MBD3 G6PC3 SPRYD4	3.64e-05	189	145	6	2cb730488709bcb56ce3468f3d74366d8bce9c72
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIBP2 FAM221A SHH PGAP4 GINS1 KBTBD11	3.75e-05	190	145	6	5b3f773380aef4773b70f0dbd74992d28e6586c6
ToppCell	P03-Endothelial-large_vessel_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF ARPC1B RBP7 MOXD1 SAT1 EPAS1	3.86e-05	191	145	6	b680e0c35f1004be36f9f0680ae3c62952e2b607
ToppCell	P07-Endothelial-large_vessel_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF ARPC1B RBP7 MOXD1 SAT1 EPAS1	3.86e-05	191	145	6	d162917816dd2e4767c97447c1cddae9397713ab
ToppCell	18-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	CYP2A6 CYP2A7 CYP2A13 GLRA3 ITIH2 SAT1	3.97e-05	192	145	6	9fae988ecd2ef1231bfd42a678a4903517694cbe
ToppCell	droplet-Tongue-nan-3m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 PPFIBP2 ADM CELSR2 EFHD1 DHX32	4.21e-05	194	145	6	592e8c4b73ba424a52305ac411ea9c0a2dc44467
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DAGLB ASAH2 MYO18A LRRN2	4.39e-05	60	145	4	28415d543aaccc74d19e1bb92b7e6fa94f97f8f2
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DAGLB ASAH2 MYO18A LRRN2	4.39e-05	60	145	4	71eba0fbef11cfc2b1c525d5f051530750e4fce9
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC16A9 PPFIBP2 KMT5C TMEM132C CELSR2 DHODH	4.45e-05	196	145	6	efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VMP1 FLNA WEE1 MOXD1 SEMA6D CELSR2	4.45e-05	196	145	6	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LANCL1 PTK2 RBP7 EFHD1 RAB40B SLC25A48	4.58e-05	197	145	6	032ccc91e604113da9bc34a6f9ddb1d45dea1892
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	OR2L3 OR2L5 MYO18A LANCL1 EFHD1 RAB40B	4.58e-05	197	145	6	54fb207638e211f8efdb13003ae62a6b1f003b09
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FLNA ACTN2 MOXD1 EFHD1 PNCK ADPRHL1	4.71e-05	198	145	6	1e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNA ACTN2 ADM GET4 RIPOR1 EPAS1	4.85e-05	199	145	6	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GALNT15 CNTN4 SLC16A9 MOXD1 SEMA3B ADAMTS16	4.85e-05	199	145	6	6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|Endothelial_cells / Location, Cell class and cell subclass	GALNT15 FLNA VWF ABL2 ARPC1B RBP7	4.98e-05	200	145	6	9c1b30fa96565515a7160f439cadcd51482c41e9
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ASAH2 SHH FZD6 TMEM132C ADM	5.79e-05	126	145	5	3539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 EXOC6 VWF PAQR4 RIPOR1	9.22e-05	139	145	5	b07929348ec9ad95d7bce33a7deac0938227b19f
Computational	AcetylCholine receptors.	GLRA3 GLRA1 GLRA2	1.52e-04	14	83	3	MODULE_328
Computational	Neurotransmitter (GABA) receptor.	GLRA3 GLRA1 GLRA2	1.89e-04	15	83	3	MODULE_215
Computational	Genes in the cancer module 267.	GLRA3 GLRA1 GLRA2	1.89e-04	15	83	3	MODULE_267
Drug	L-serinamide	GLRA3 SHMT2 GLRA1 GLRA2	5.15e-08	7	143	4	CID000101138
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	2.43e-07	3	143	3	CID000068481
Drug	protostrychnine	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID005320746
Drug	7-nitroindoline	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID013566747
Drug	SC-49648	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000195696
Drug	akuammiline	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID005367018
Drug	N-methyl-THIP	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000134373
Drug	SC-48981	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000126573
Drug	iso-THAZ	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID003047783
Drug	2-(phosphonomethyl)phenylalanine	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000383689
Drug	NSC381080	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000165497
Drug	SC-50132	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000195719
Drug	SR 42641	GLRA3 GLRA1 GLRA2	9.66e-07	4	143	3	CID000129049
Drug	ACEA-1011	GLRA3 GRIN2D GLRA1 GLRA2	1.93e-06	15	143	4	CID000127872
Drug	Lindane	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	DB00431
Drug	pleiocarpamine	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000558637
Drug	azetidine-3-carboxylic acid	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000093192
Drug	Cao C	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000166617
Drug	oxanilide	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000069288
Drug	iso-THAO	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000127199
Drug	ALX1393	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID016078939
Drug	mafoprazine	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000071241
Drug	gevotroline	GLRA3 GLRA1 GLRA2	2.40e-06	5	143	3	CID000060546
Drug	LY233536	GLRA3 GRIN2D GLRA1 GLRA2	2.56e-06	16	143	4	CID000126239
Drug	7-Cl-Thio-Kyna	GLRA3 GRIN2D GLRA1 GLRA2	3.33e-06	17	143	4	CID003035668
Drug	MNQX	GLRA3 GRIN2D GLRA1 GLRA2	4.26e-06	18	143	4	CID000130818
Drug	THAZ	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000171289
Drug	thiomuscimol	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000005448
Drug	thio-THIP	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000656720
Drug	AC1L90PQ	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000436036
Drug	mV GABA	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000128435
Drug	caged glycine	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000192642
Drug	brometone	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000006424
Drug	minaxolone	GLRA3 GLRA1 GLRA2	4.79e-06	6	143	3	CID000071960
Drug	N,N-dimethylaniline	CYP2A7 CYP2A13 MOXD1 G6PC3 SPAG17	6.43e-06	42	143	5	CID000000949
Drug	Boc-glycine	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000078288
Drug	alpha-EMTBL	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000128423
Drug	CID189778	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000189778
Drug	propyl methanethiosulfonate	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000529387
Drug	thiocolchicoside	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000072067
Drug	PK 8165	GLRA3 GLRA1 GLRA2	8.34e-06	7	143	3	CID000071219
Drug	WT702	GLRA3 GLRA1 GLRA2	1.33e-05	8	143	3	CID000089643
Drug	isostrychnine	GLRA3 GLRA1 GLRA2	1.33e-05	8	143	3	CID000264626
Drug	NSC129536	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID000004815
Drug	Atonik	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID000069471
Drug	nortropanol	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID000068147
Drug	AC1NSJX8	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID005311059
Drug	SR 57227A	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID000131746
Drug	DCQX	GLRA3 GLRA1 GLRA2	1.98e-05	9	143	3	CID000001845
Drug	L-689,560	GLRA3 GRIN2D GLRA1 GLRA2	2.34e-05	27	143	4	CID000121918
Drug	BN52020	CYP2A6 GLRA3 GLRA1 GLRA2	2.72e-05	28	143	4	CID000115221
Drug	THBA	GLRA3 GLRA1 GLRA2	2.82e-05	10	143	3	CID000130993
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	HBS1L TUSC2 PTK2 ITPR2 SAT1 CANT1 EPAS1 SLC27A5	2.87e-05	191	143	8	1561_UP
Drug	AC1NUW3V	GLRA3 GRIN2D GLRA1 GLRA2	3.14e-05	29	143	4	CID005462126
Drug	Debrisoquin sulfate [581-88-4]; Down 200; 9uM; HL60; HG-U133A	HBS1L ABL1 HYOU1 TUSC2 SHMT2 TTBK2 SAT1 STAG2	3.45e-05	196	143	8	1591_DN
Drug	Glycine	GLRA3 SHMT2 GLRA1 GLRA2	3.60e-05	30	143	4	DB00145
Drug	bilobalide	CYP2A6 GLRA3 GLRA1 GLRA2	3.60e-05	30	143	4	CID000073581
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	FLNA PDK2 PPFIBP2 PTK2 HMG20B MTOR NFKBIB RIPOR1	3.70e-05	198	143	8	4825_DN
Drug	Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A	GLRA3 PGAP4 MBD3 ITIH2 ITPR2 SEMA6D NFKBIB SEMA3B	3.70e-05	198	143	8	6520_UP
Drug	ip 0	GLRA3 GLRA1 GLRA2	3.86e-05	11	143	3	CID000006943
Drug	propargyl ether	CYP2A6 CYP2A13	3.92e-05	2	143	2	ctd:C531209
Drug	Hempa	CYP2A6 CYP2A13	3.92e-05	2	143	2	ctd:D006492
Drug	nicotine imine	CYP2A6 CYP2A13	3.92e-05	2	143	2	ctd:C034629
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	3.92e-05	2	143	2	ctd:C008615
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	3.92e-05	2	143	2	ctd:C036676
Drug	NPC 12626	GLRA3 GRIN2D GLRA1 GLRA2	4.11e-05	31	143	4	CID000108099
Drug	LY235959	GLRA3 GRIN2D GLRA1 GLRA2	4.11e-05	31	143	4	CID000131938
Drug	eliprodil	GLRA3 GRIN2D GLRA1 GLRA2	4.11e-05	31	143	4	CID000060703
Drug	indole-2-carboxylic acid	GLRA3 GRIN2D GLRA1 GLRA2	4.68e-05	32	143	4	CID000072899
Drug	colchicoside	GLRA3 GLRA1 GLRA2	5.12e-05	12	143	3	CID000092763
Drug	1,12-dimethylspermine	PTK2 SAT1 SMS	5.12e-05	12	143	3	CID003081835
Drug	harmaline	GLRA3 SLC9A5 GLRA1 GLRA2	5.98e-05	34	143	4	CID000022381
Drug	L-cycloserine	GLRA3 SHMT2 GRIN2D GLRA1 GLRA2	5.98e-05	66	143	5	CID000000401
Drug	NSC20257	CYP2A13 POLR1A SHMT2 ITIH2 CANT1 ENTPD6 DHODH ELAVL4	6.20e-05	213	143	8	CID000001172
Drug	C6H12NO5P	GLRA3 GRIN2D GLRA1 GLRA2	7.52e-05	36	143	4	CID000104962
Drug	felbamate	GLRA3 GRIN2D GRM4 GLRA1 GLRA2	7.94e-05	70	143	5	CID000003331
Drug	N-nitrosomethylaniline	CYP2A6 CYP2A7 CYP2A13	8.39e-05	14	143	3	CID000011957
Drug	Adomdb	LANCL1 SMS STAG2	8.39e-05	14	143	3	CID000188380
Drug	ABPH	GLRA3 GLRA1 GLRA2	8.39e-05	14	143	3	CID000092377
Drug	quinoxaline-2,3-dione	GLRA3 GLRA1 GLRA2	8.39e-05	14	143	3	CID011469229
Drug	DETA	CYP2A6 PTK2 SEMA3A SEMA6D SEMA3B SPAG17	8.44e-05	114	143	6	CID000004284
Drug	NSC-88789	GLRA3 GRIN2D GLRA1 GLRA2	1.03e-04	39	143	4	CID000002748
Drug	HA-966	GLRA3 GRIN2D GLRA1 GLRA2	1.03e-04	39	143	4	CID000001232
Drug	milacemide	GLRA3 GLRA1 GLRA2	1.04e-04	15	143	3	CID000053568
Drug	aspartate	GLS2 GLRA3 SHMT2 GRIN2D GRM4 ARPC1B PTK2 G6PC3 GLRA1 GLRA2 DHODH SLC37A4	1.08e-04	518	143	12	CID000000424
Drug	taurine	LANCL1 GRIN2D MTOR GLRA1 GLRA2 LRRN2 MAPK6 SLC27A5	1.09e-04	231	143	8	CID000001123
Drug	cyanotriphenylborate	GLRA1 GLRA2	1.17e-04	3	143	2	CID000151925
Drug	7-chloro-4-quinolinol	GLRA1 GLRA2	1.17e-04	3	143	2	CID000066593
Drug	alpha-aminoisobutyric acid	PSMB4 GLRA3 GLRA1 GLRA2	1.26e-04	41	143	4	CID000006119
Drug	AC1NBK95	ABL1 MTOR GLCE	1.28e-04	16	143	3	CID004469365
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	EPPK1 ADM TTBK2 SAT1 ABTB2 EPAS1 MAST3	1.31e-04	177	143	7	7555_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PPFIBP2 ADM TTBK2 SAT1 RAB40B EPAS1 MAST3	1.31e-04	177	143	7	4954_UP
Drug	PD153035	DAGLB PPFIBP2 PTK2 SEMA3A MTOR MAPK6	1.53e-04	127	143	6	CID000004705
Drug	zatosetron	GLRA3 GLRA1 GLRA2	1.55e-04	17	143	3	CID000060763
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PPFIBP2 ADM SAT1 GLCE RAB40B CHST7 MAST3	1.56e-04	182	143	7	5511_UP
Drug	angiogenesis inhibitor	VWF SHMT2 SEMA3A GLCE SEMA3B EPAS1	1.60e-04	128	143	6	CID002812173
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	ABL2 HYOU1 MPDZ ITIH2 SAT1 CELSR2 SEMA3B	1.72e-04	185	143	7	1226_UP
Drug	7-chlorokynurenic acid	GLRA3 GRIN2D GLRA1 GLRA2	1.82e-04	45	143	4	CID000001884
Drug	memantine	GLRA3 GRIN2D GRM4 GLRA1 GLRA2	2.11e-04	86	143	5	CID000004054
Drug	2f4b	ITIH2 GRK1 MOXD1	2.18e-04	19	143	3	CID006102812
Disease	pulmonary hypertension (is_implicated_in)	VWF PTK2 ADM EPAS1	1.28e-05	30	142	4	DOID:6432 (is_implicated_in)
Disease	depressive symptom measurement, herpes virus seropositivity	ASAH2 TMEM132C	2.28e-04	5	142	2	EFO_0007006, EFO_0007036
Disease	serum alanine aminotransferase measurement	DAGLB GALNT15 CYP2A6 HYOU1 SHH BAZ1B HKDC1 GINS1 CELSR2 EFHD1 DHODH SLC37A4 MAST3	3.04e-04	869	142	13	EFO_0004735
Disease	Epileptic encephalopathy	FLNA MTOR ALG13	4.03e-04	30	142	3	C0543888
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A4 ATP4A	4.75e-04	7	142	2	DOID:0060178 (implicated_via_orthology)
Disease	congenital disorder of glycosylation type II (is_implicated_in)	GET4 SLC37A4	4.75e-04	7	142	2	DOID:0050571 (is_implicated_in)
Disease	catalase measurement	CELSR2 ABTB2	4.75e-04	7	142	2	EFO_0008071
Disease	Large cell carcinoma of lung	ABL1 ATR MTOR	4.89e-04	32	142	3	C0345958
Disease	glucose measurement	GLS2 ZAN PPFIBP2 EML6 MADD TMEM132C OR4S1 SPRYD4	5.27e-04	380	142	8	EFO_0004468
Disease	glycine measurement	CYP2A6 GLS2 PPFIBP2 SPRYD4 MAST3	5.40e-04	137	142	5	EFO_0009767
Disease	focal segmental glomerulosclerosis (is_marker_for)	VWF SHH	6.32e-04	8	142	2	DOID:1312 (is_marker_for)
Disease	holoprosencephaly (is_implicated_in)	SHH STAG2	6.32e-04	8	142	2	DOID:4621 (is_implicated_in)
Disease	uric acid measurement	VMP1 CNTN4 DNAH3 POLR1A SLC16A9 BAZ1B GUCY2D UMOD EPAS1 SLC27A5	7.68e-04	610	142	10	EFO_0004761
Disease	Alzheimer disease, fasting blood glucose measurement	MADD OR4S1	8.10e-04	9	142	2	EFO_0004465, MONDO_0004975
Disease	Carcinoma, Small Cell	CYP2A6 MTOR	8.10e-04	9	142	2	C0262584
Disease	lipoprotein-associated phospholipase A(2) measurement	VMP1 CELSR2 GLCE	9.46e-04	40	142	3	EFO_0004746
Disease	glutamine measurement, amino acid measurement	GLS2 SPRYD4	1.23e-03	11	142	2	EFO_0005134, EFO_0009768
Disease	immunoglobulin isotype switching measurement	UBR4 ATP1A4 TAP2	1.25e-03	44	142	3	EFO_0010128
Disease	schizophrenia (is_marker_for)	VWF GRIN2D ARPC1B	1.25e-03	44	142	3	DOID:5419 (is_marker_for)
Disease	ureteral obstruction (biomarker_via_orthology)	ABL1 ADM MTOR	1.34e-03	45	142	3	DOID:5199 (biomarker_via_orthology)
Disease	urate measurement	VMP1 DNAH3 GLS2 SLC16A9 SHH BAZ1B SHMT2 UMOD TAP2 EPAS1 SPRYD4 MAST3	1.34e-03	895	142	12	EFO_0004531
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	1.47e-03	12	142	2	EFO_0007794
Disease	nervous system disease (implicated_via_orthology)	ATP1A4 ATP4A	1.47e-03	12	142	2	DOID:863 (implicated_via_orthology)
Disease	Alcoholic Intoxication, Chronic	CNTN4 CYP2A13 VWF MPDZ SAT1 ANAPC1	1.94e-03	268	142	6	C0001973
Disease	1-methylurate measurement	CNTN4 SEMA3A	2.01e-03	14	142	2	EFO_0021173
Disease	Glioblastoma Multiforme	PDK2 PTK2 MTOR STAG2	2.07e-03	111	142	4	C1621958
Disease	lipoprotein A measurement	GLS2 BAZ1B CELSR2 SPRYD4	2.14e-03	112	142	4	EFO_0006925
Disease	diabetic retinopathy (is_marker_for)	VWF ADM KDM1A	2.26e-03	54	142	3	DOID:8947 (is_marker_for)
Disease	Metastatic melanoma	PTK2 MTOR GUCY2D	2.26e-03	54	142	3	C0278883
Disease	Neoplasm of uncertain or unknown behavior of bladder	MTOR STAG2	2.32e-03	15	142	2	C0496930
Disease	Benign neoplasm of bladder	MTOR STAG2	2.32e-03	15	142	2	C0154017
Disease	Carcinoma in situ of bladder	MTOR STAG2	2.32e-03	15	142	2	C0154091
Disease	serum albumin measurement	VMP1 CYP2A6 CYP2A7 HBS1L GLS2 MADD DHODH SLC37A4 SPRYD4	2.34e-03	592	142	9	EFO_0004535
Disease	hearing threshold measurement, hearing measurement	SLC16A9 MYO18A SLC7A14	3.20e-03	61	142	3	EFO_0007616, EFO_0007618
Disease	Carcinoma of bladder	MTOR STAG2	3.35e-03	18	142	2	C0699885
Disease	sensorineural hearing loss (implicated_via_orthology)	SLC7A14 DNAH9	3.73e-03	19	142	2	DOID:10003 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR EPAS1	3.73e-03	19	142	2	DOID:0080322 (biomarker_via_orthology)
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7	3.73e-03	19	142	2	EFO_0007872
Disease	Liver Cirrhosis, Experimental	FLNA VWF GLS2 ARPC1B CIDEA ADM SEMA6D RAB40B TAP2 SLC37A4	4.35e-03	774	142	10	C0023893

Protein segments in the cluster

Peptide	Gene	Start	Entry
ARGLEFLMILGTESY	CATSPERG	456	Q6ZRH7
GMASRLLGPSFESYL	EPAS1	821	Q99814
EDFRACLISMGYDLG	ACTN2	776	P35609
GYDLGEAEFARIMTL	ACTN2	786	P35609
SMDEYLGSLGLFRKL	ALG13	221	Q9NP73
FLRGYLSGQSLAETM	CEP19	76	Q96LK0
GEGLARMELFLFFTT	CYP2A6	441	P11509
ADFGLSRLMTGDTYT	ABL2	426	P42684
SLMEALSADKGGFLY	BAZ1B	636	Q9UIG0
TYDAAAGMLSFGGRL	ARPC1B	271	O15143
RIFLGLGMSISYAAL	GRM4	656	Q14833
TGMDFRYSVVEGSLL	CNTN4	71	Q8IWV2
SGTIYDLRHFMLGIA	GLCE	556	O94923
AAMAIASLNGYRLGD	ELAVL4	356	P26378
GEAGRLEYTMDALFD	CELSR2	211	Q9HCU4
LSGYFMQIARDVDGS	DHX32	621	Q7L7V1
GLSGMIRTEEADYFL	ADAMTS16	166	Q8TE57
VALMYLGSLAFLGAD	ADM	6	P35318
LGGAEALLLASMAYD	OR2L3	106	Q8NG85
MSALGSPVRAYDFLL	RAB40B	1	Q12829
FLDKLMGRTSGYDAR	GLRA3	46	O75311
VIAADMLGSYGSLAR	PSMB4	66	P28070
MADALLERGYSLVSG	SHMT2	361	P34897
GTFTRGYRAVILDMA	ITPR2	2331	Q14571
ELGRFMLRYGGSTIA	HBS1L	661	Q9Y450
AELANEYAGFLMALG	ANAPC1	1166	Q9H1A4
RESYSLAAGLALGMV	ANAPC1	1291	Q9H1A4
GSSVGLFIYAALQRM	SLC16A9	146	Q7RTY1
LGGAECFLLAAMAYD	OR10AC1	111	Q8NH08
EGFGGIMSFASSLYR	MADD	841	Q8WXG6
SLFEGMAGTIYFLAD	LANCL1	371	O43813
ISLFSLGMGFDVDYD	ITIH2	446	P19823
RYLGGSMDLSTFDFR	MBD3	51	O95983
DTDAAGDRLFATYML	GUCY2D	406	Q02846
GDRLFATYMLDPARG	GUCY2D	411	Q02846
GLLRAGENDFSIMYS	KMT5C	151	Q86Y97
AGMNLREISDYALEG	LRRN2	221	O75325
RLYSRAFIMAEPDGS	ASAH2	136	Q9NR71
YGGITEFVADFRLML	KIAA2026	151	Q5HYC2
PMERELSFYGLTALA	G6PC3	191	Q9BUM1
AYDSLMSLRGGENLE	GALNT15	381	Q8N3T1
DSGRVASYIMAFTLD	CANT1	366	Q8WVQ1
YRDLSGMFTTESRLG	CPSF1	701	Q10570
FLLGFSAGTEYMDLQ	NFKBIB	76	Q15653
ESLMNIHGFDLGSRY	MAPK6	6	Q16659
FAGAEALLLTSMAYD	OR2L5	106	Q8NG80
LGGAEALLLASMAYD	OR2L8	106	Q8NGY9
GGTEIFLLTAMAYDR	OR4S1	106	Q8NGB4
LGSEENGRYFSLSLM	PCDHGC5	66	Q9Y5F6
NGRYFSLSLMSGALA	PCDHGC5	71	Q9Y5F6
CLEGMAAGLYSELFT	MYO18A	751	Q92614
SGMLSRLGDLLFYTI	GLS2	66	Q9UI32
FFSLYSMGLVELVGR	PGAP4	296	Q9BRR3
DGRASGYLMDLINFL	EXOC6	626	Q8TAG9
YTDTLGMAEFRRGGL	PPFIBP2	516	Q8ND30
QGGSAVYARLLALDM	PAQR4	106	Q8N4S7
LFSMEGFGTDAVIYL	PDK2	346	Q15119
LYLAMELVTGGELFD	PNCK	86	Q6P2M8
MLGNYSSATEFFLLG	OR9A1P	1	Q8NGU1
LMYFIGFLLGDSTAC	FZD6	246	O60353
GSIAAGYLSDRAMAK	SLC37A4	276	O43826
GVEDSSFAYGLLMEL	ATR	1386	Q13535
GMVLNYSRSLAEDFA	HYOU1	151	Q9Y4L1
EAGRIADQFLGAMYT	KDM1A	821	O60341
ATLNGLMYFVRDDSA	KLHL21	466	Q9UJP4
GEGLARMELFLFFTT	CYP2A13	441	Q16696
LIGEISLYSMGFLDS	DNAH3	1561	Q8TD57
GGAAALLATMLRAAY	DAGLB	446	Q8NCG7
RGAGSYTIMVLFADQ	FLNA	841	P21333
GEGLARMELFLFFTT	CYP2A7	441	P20853
YVSRLMEALGEFRGT	FNIP2	371	Q9P278
LLNFMIAAYDSEGRG	DTNB	111	O60941
DFGLSRLMTGDTYTA	ABL1	381	P00519
AAMLLGSVGDALGYR	ADPRHL1	6	Q8NDY3
DFLDKLMGRTSGYDA	GLRA2	46	P23416
GFSLRAIRVYMGDSD	MAST3	961	O60307
LYDAGRDGFIDLMEL	EFHD1	101	Q9BUP0
YGRMEDLVFSGAATG	EML6	871	Q6ZMW3
VGMAFARLEEGYESA	DNAH9	1731	Q9NYC9
GFSSLAEGYMRLDDS	FAM221A	196	A4D161
FALGVTLYEMIAARG	GRK1	376	Q15835
LDIVAMFRQYSGDDG	S100A7L2	11	Q5SY68
TEGLSLVYMAARLDG	METTL17	151	Q9H7H0
LVYMAARLDGGFAAV	METTL17	156	Q9H7H0
SELTLGNAMGYRDRF	ATP4A	471	P20648
GDLDSFFLAAMAYDR	OR1N1	106	Q8NGS0
GGSEVFLLLVMAYDR	OR4A4P	106	Q8NGN8
GRLAMAGDTFTAEYV	MTOR	131	P42345
TLGTLDFYMARLHGA	HMG20B	276	Q9P0W2
AESDLAYTRAIMGSG	SMS	171	P52788
RLQGISFGMYSAEEL	POLR1A	11	O95602
SKYGMLARLAVEAGF	SHH	156	Q15465
SSLALFRDDMGVKYG	SPRYD4	41	Q8WW59
SDLEIGMYALLGVFC	TMEM132C	921	Q8N3T6
SYSYLGLGLMSARLA	ENTPD6	291	O75354
EARELMYSGALLFFS	GET4	61	Q7L5D6
IADFLDYMGLKGASL	HKDC1	581	Q2TB90
LCEDLLYGRMSFRGF	MPHOSPH6	66	Q99547
KLGDFGLSRYMEDST	PTK2	561	Q05397
FLDKLMGRTSGYDAR	GLRA1	41	P23415
DTGLYMLQLAGRGSA	EPPK1	3476	P58107
GLLFASYLMATGDER	DHODH	21	Q02127
LGLAAMGTARQDVYD	PSMD1	481	Q99460
VMSYGGLRGAVAFAL	SLC9A5	401	Q14940
DGELTQGSLLSFMIY	TAP2	401	Q03519
VMSDYRGFGIGSEIL	SAT1	96	P21673
NEGLAGLYRGASAML	SLC25A48	171	Q6ZT89
MFLGYELSLQAIRGD	SLC25A48	291	Q6ZT89
LIDGELYSGTAADFM	SEMA3A	181	Q14563
LGYSSAIAPRMLADF	OR5AR1	71	Q8NGP9
LLLADAYSGRMAGVR	KBTBD11	186	O94819
LGLLEEALFYGTRTM	SMYD3	341	Q9H7B4
ESYDIAMRFLSSIGG	SRBD1	831	Q8N5C6
YMLDGSTQILFADGA	SPAG17	1296	Q6Q759
YADGSGMELLRDSDI	SPAG17	1646	Q6Q759
GMFSAEPYLRLESAG	SHANK1	1291	Q9Y566
ALSLYSMSAGDGLRR	ABTB2	181	Q8N961
AAFLSYTPGMDVALR	ATP1A4	971	Q13733
DYAGALIRPLTFMGS	CIDEA	6	O60543
LDAFALNMTRGAAYG	CHST7	401	Q9NS84
IYAMAGDGLLFRFLA	SLC7A14	361	Q8TBB6
LGGAVEDYFMRNADL	TSR2	46	Q969E8
GGSLADAISENYRIM	WEE1	381	P30291
GQLGYLRFDAMAELE	RBP3	741	P10745
YVGTMLDGGDLSRFA	UMOD	486	P07911
GDALGFAVRYLTSEM	VWF	1771	P04275
GRVMALDIFSSYTGR	MPDZ	1106	O75970
GLIDNSGLRLFYTMD	MOXD1	316	Q6UVY6
DIFAIGSLMDDYLGL	POLR2G	156	P62487
YNTGDVLAMDREGFL	SLC27A5	531	Q9Y2P5
LMSYRNSLLAGGDDD	STAG2	1041	Q8N3U4
EGMAAGTFLYITFLE	SLC39A1	276	Q9NY26
YSGVAADLMGRDFTI	SEMA3B	186	Q13214
LLSSDNFEGYMLALG	RBP7	11	Q96R05
SSMGERILDAGDYDL	SYCP2	201	Q9BX26
GIYSSTEMLDFGTLR	TMEM131	321	Q92545
GFGEIYDALDMLTRE	TTBK2	31	Q6IQ55
TRRGSMFYDEDGDLA	TUSC2	46	O75896
DGTLLAMGSYDGFAR	TBL1Y	246	Q9BQ87
IAGLSYSGDFRMVVG	TAMM41	181	Q96BW9
MLEGGSLSSAEYEAR	VWA5B2	281	Q8N398
RLFGGSSDLMDYDNV	TXNRD2	381	Q9NNW7
GSADGRVLMYSFRTA	WDR25	491	Q64LD2
LATYMRSLGGDEGLD	GINS1	121	Q14691
AISEERLREMFGLYG	SAR1B	141	Q9Y6B6
FLASDAVIYRSMGDG	SEMA6D	191	Q8NFY4
AVIYRSMGDGSALRT	SEMA6D	196	Q8NFY4
LGMDLDLASGCLTFY	TRIM65	451	Q6PJ69
VYRMRGLLGDATEEF	UBR4	4441	Q5T4S7
EALGALMAALDDYRG	RIPOR1	796	Q6ZS17
GFTMDEVDSLLSRYA	ZFYVE26	1711	Q68DK2
MRDAVFGLGNSAYAS	TYW1B	126	Q6NUM6
RSFRSGDGLQLEYEM	TMEM145	136	Q8NBT3
LMFEGTRGSTAYLDI	ZAN	176	Q9Y493
YFMARAARLSGAEPD	VMP1	206	Q96GC9
GEVFYQRADMAIGSL	GRIN2D	526	O15399